| P2093 | author name string | Yuan Lin | |
| | Jia Chen | |
| | Li-Li | |
| | Lin-Hai Yan | |
| | Jian-Si Chen | |
| | Wen-E Wei | |
| | Xian-Wei Mo | |
| | Yu-Zhou Qin | |
| | Zhi-Ning Chen | |
| P2860 | cites work | Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer | Q26752006 |
| | Providing a molecular mechanism for P-glycoprotein; why would I bother? | Q26777721 |
| | MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. | Q33967256 |
| | MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas | Q34148960 |
| | miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. | Q34206812 |
| | Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study | Q34643128 |
| | Redox regulation of cardiomyocyte cell cycling via an ERK1/2 and c-Myc-dependent activation of cyclin D2 transcription | Q35033118 |
| | Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer | Q35201375 |
| | Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy | Q35212176 |
| | miRNA regulation of cytotoxic effects in mouse Sertoli cells exposed to nonylphenol | Q35389756 |
| | ICE1 of Poncirus trifoliata functions in cold tolerance by modulating polyamine levels through interacting with arginine decarboxylase | Q35666816 |
| | The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. | Q35793635 |
| | GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells | Q35795342 |
| | A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient βcatenin destruction | Q36056178 |
| | miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo | Q36610611 |
| | The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer | Q36729463 |
| | Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome | Q36998156 |
| | Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation | Q37009280 |
| | MicroRNAs in development and disease | Q37899669 |
| | CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response | Q38379668 |
| | Cancer Prevention Research in China. | Q38528120 |
| | miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. | Q38826529 |
| | Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance | Q38915770 |
| | miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer | Q38957909 |
| | MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression | Q39017434 |
| | miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway. | Q39026464 |
| | Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo | Q39095784 |
| | Identification of microRNAs associated with lymphangiogenesis in human gastric cancer | Q39121020 |
| | Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma | Q39240032 |
| | MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation | Q39400620 |
| | MiR-135a functions as a selective killer of malignant glioma. | Q39433440 |
| | miR-135a modulates tendon stem/progenitor cell senescence via suppressing ROCK1. | Q41743120 |
| | DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function | Q46561692 |
| | AutomiRDB: a web resource connecting microRNAs and autophagy in cancer | Q47935194 |
| | Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin. | Q53570001 |
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oxaliplatin | Q422327 |
| P304 | page(s) | 70699-70714 | |
| P577 | publication date | 2016-09-23 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | miR-135a promotes gastric cancer progression and resistance to oxaliplatin | |
| P478 | volume | 7 | |